1.4600
-0.0500
(-3.31%)
At close: January 10 at 4:00:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-46,706.0000
-55,657.0000
-63,760.0000
-46,571.0000
-32,739.0000
Investing Cash Flow
43,020.0000
-50,545.0000
-1,368.0000
-143,584.0000
27,911.0000
Financing Cash Flow
429.0000
35,577.0000
958.0000
2,022.0000
292,972.0000
End Cash Position
49,622.0000
38,528.0000
109,119.0000
173,289.0000
361,422.0000
Income Tax Paid Supplemental Data
--
--
--
23.0000
6.0000
Capital Expenditure
-796.0000
-962.0000
-7,984.0000
-1,349.0000
-148.0000
Issuance of Capital Stock
--
35,121.0000
--
--
292,966.0000
Free Cash Flow
-47,502.0000
-56,619.0000
-71,744.0000
-47,920.0000
-32,887.0000
12/31/2020 - 9/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HLVX HilleVax, Inc.
2.0500
-1.91%
PRLD Prelude Therapeutics Incorporated
1.0600
-7.02%
IKNA Ikena Oncology, Inc.
1.5600
-2.50%
GBIO Generation Bio Co.
0.9255
+1.69%
TBPH Theravance Biopharma, Inc.
8.78
-2.98%
KZR Kezar Life Sciences, Inc.
6.51
-1.06%
BOLT Bolt Biotherapeutics, Inc.
0.5387
-4.69%
LYEL Lyell Immunopharma, Inc.
0.6040
-7.32%
ACHL Achilles Therapeutics plc
1.1850
-0.42%
KRON Kronos Bio, Inc.
0.9564
-2.90%